Le Lézard
Classified in: Health
Subjects: LEG, POL

Statement by U.S. Conference of Mayors on President Biden's Executive Order Protecting Access to Reproductive Health Care Services


WASHINGTON, July 8, 2022 /PRNewswire/ -- Below is a statement by U.S. Conference of Mayors CEO and Executive Director, Tom Cochran, on the Executive Order signed by President Biden today protecting access to reproductive health care services:

"America's mayors applaud the efforts by President Biden and the Executive Branch to protect access to reproductive health care services in the wake of the devastating Supreme Court decision in Dobbs. Today's Executive Order will also protect patient privacy and access to accurate information and promote the safety and security of patients, providers, and clinics. We further appreciate the Attorney General's pledge on June 24 that the Justice Department will work tirelessly to protect and advance reproductive freedom.

"Just last month the Conference of Mayors adopted policy registering the organization's support for a woman's constitutional right to choose and calling on Congress to swiftly pass legislation to codify that right. We will do everything we can to help to make that happen but appreciate in the meantime the importance of this Executive Order and the support it provides to women across the country."

About the United States Conference of Mayors -- The U.S. Conference of Mayors is the official nonpartisan organization of cities with populations of 30,000 or more. There are more than 1,400 such cities in the country today, and each city is represented in the Conference by its chief elected official, the mayor. Like us on Facebook or follow us on Twitter.

SOURCE U.S. Conference of Mayors


These press releases may also interest you

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 09:18
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...



News published on and distributed by: